The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare neurological condition that can cause paralysis. The ruling will
read moreFollowing the departure of its global managing director of health and life sciences for a new role at Takeda last fall, FleishmanHillard has now tapped Mary Kosinski to take the reins of its largest sector. More: FleishmanHillard names BeiGene, HHS
read moreSwoop has taken control of more than 60 patient communities by acquiring MyHealthTeam, positioning the Real Chemistry spinout to offer new communication options to its pharma clients. More: Swoop scoops up MyHealthTeam, buying patient social networks to boost pharma marketing
read moreArmgo Pharma is making a fresh start this new year, as the Boston-based biotech announced Tuesday that it will henceforth be known as RyCarma Therapeutics. More: Letting go of Armgo: Biotech rebrands as RyCarma Therapeutics Source: fierce
read moreVerona Pharma is off to a promising start as it launches its first product, Ohtuvayre, a maintenance treatment for chronic obstructive pulmonary disorder (COPD). In 2024, Ohtuvayre generated sales of $42 million, the company reported on Tuesday. More: Verona touts 'exceptionally
read more
OAV101 IT expands potential for type II SMA patients More: Novartis gene therapy set to enhance SMA treatment Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals